Home/Supreme Court/Mylan Laboratories, Inc. v. Blue Cross Blue Shield of Massachusetts

Mylan Laboratories, Inc. v. Blue Cross Blue Shield of Massachusetts

181 L. Ed. 2d 234, 132 S. Ct. 368, 565 U.S. 930, 2011 U.S. LEXIS 7064, 80 U.S.L.W. 3192
CourtSupreme Court of the United States
DecidedOctober 3, 2011
DocketNo. 10-1500
StatusPublished

This text of 181 L. Ed. 2d 234 (Mylan Laboratories, Inc. v. Blue Cross Blue Shield of Massachusetts) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mylan Laboratories, Inc. v. Blue Cross Blue Shield of Massachusetts, 181 L. Ed. 2d 234, 132 S. Ct. 368, 565 U.S. 930, 2011 U.S. LEXIS 7064, 80 U.S.L.W. 3192 (U.S. 2011).

Opinion

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.

The Chief Justice took no part in the consideration or decision of this petition.

Same case below, 394 U.S. App. D.C. 108, 631 F.3d 537.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Blue Cross & Blue Shield v. Mylan Laboratories, Inc.
631 F.3d 537 (D.C. Circuit, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
181 L. Ed. 2d 234, 132 S. Ct. 368, 565 U.S. 930, 2011 U.S. LEXIS 7064, 80 U.S.L.W. 3192, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mylan-laboratories-inc-v-blue-cross-blue-shield-of-massachusetts-scotus-2011.